PFIZER

Insight
More news
People walk past the Pfizer World headquarters in New York

Pfizer Gets Refusal-To-File Letter For Tafamidis NDA

Pfizer Inc. (NYSE: PFE) said on Monday it has received a Refusal-to-File letter from the United States Food and Drug Administration (FDA) for tafamidis, the company’s oral investigational compound for patients with Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).
Biogen Idec

Biogen Idec Stock Can Appreciate to Mid $70s: Analyst

Biogen Idec stock price can appreciate to the mid $70s based on five areas of potential upside, according to RBC Capital Markets. The brokerage upgraded its rating on shares of the biotechnology company to outperform from sector perform and increased its price target to $75 from $60.
Pfizer, BYU Go To Court In May, Celebrex and Millions Of Dollars At Stake

Pfizer settles remaining Nigeria, US Trovan suits

Pfizer Inc said it has settled all outstanding lawsuits involving accusations that it tested the experimental antibiotic Trovan on children in Nigeria during a 1996 meningitis outbreak without receiving adequate prior consent.

US stocks extend gains after ISM data

US stocks extend gains in early trade on Tuesday after a report showed that manufacturing activity rose at a faster pace than expected in January.
IBTimes Logo

Mylan, Pfizer settle patent disputes over Lipitor, Caduet

U.S. generic drug maker Mylan Inc has settled two U.S. patent disputes with global pharma giant Pfizer Inc, which will enable the former to sell the generic versions of cholesterol drug Lipitor and combination blood pressure and cholesterol treatment Caduet.

China, U.S. agree to healthcare partnership

While Chinese President Hu Jintao is being entertained by U.S. President Barack Obama, and the U.S. House of Representatives votes to repeal the Obama administration’s healthcare reform law, both U.S. healthcare and Sino-American relations are the main components today of a less highly publicized event.
IBTimes Logo

Scientists find inflammation immune cell switch

Scientists have found a protein that acts as a master switch to determine whether certain white blood cells will boost or dampen inflammation, a finding that may help the search for new drugs for rheumatoid arthritis.
Novartis AG headquarters in Basel, Switzerland

Novartis Clinches Alcon In $12.9 Bln Deal

Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
Fiddausi Abdullahi Madaki, a victim of Pfizer's 1996 test, sits at her home in Kano

Pfizer sought dirt on Nigerian official to drop legal action: Wikileaks

U.S. drug giant Pfizer (NYSE: PFE) hired investigators to dig up dirt on Nigeria’s former attorney general in order to stop an investigation over a controversial drug trial the company conducted which led to the deaths of eleven children, according to cables released by WikiLeaks.
Traders work on the floor of the New York Stock Exchange

US stock futures point to lower open

Futures on the S&P 500 are down 0.30 percent to 1,219.80, futures on the Dow Jones Industrial Average are down 0.21 percent to 11,340.00 and Nasdaq100 futures are down 0.19 percent to 2,183.00.

Pages

  • MOST READ

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.